[Federal Register Volume 66, Number 84 (Tuesday, May 1, 2001)]
[Notices]
[Pages 21768-21769]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-10710]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 00N-1502]


Agency Information Collection Activities; Announcement of OMB 
Approval; Adverse Experience Reporting for Licensed Biological Products 
and General Records

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Adverse Experience Reporting for 
Licensed Biological Products and General Records'' has been approved by 
the Office of Management and Budget (OMB) under the Paperwork Reduction 
Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of December 26, 2000 
(65 FR 81528), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to,

[[Page 21769]]

a collection of information unless it displays a currently valid OMB 
control number. OMB has now approved the information collection and has 
assigned OMB control number 0910-0308. The approval expires on April 
31, 2003. A copy of the supporting statement for this information 
collection is available on the Internet at http://www.fda.gov/ohrms/dockets.

    Dated: April 24, 2001.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 01-10710 Filed 4-30-01; 8:45 am]
BILLING CODE 4160-01-S